Open Nav

 IPCC-Spring 2018 Program Agenda
*As of April 6, 2018

All sessions will take place at the Royal Sonesta New Orleans, in the Grand Ballroom, unless otherwise noted.

Wednesday, April 11, 2018

Registration Open
1:00 pm - 4:30 pm

IPCC Business Meeting & Working Luncheon
12:00 pm – 3:00 pm
*Open to IP Counsels Committee company members only
*Location Update: Royal Conti Room, Lower Level             

Refreshment Break
3:00 pm – 3:15 pm

Opening Session- Antibody Patenting: Without Exception or Eligibility
Sponsored by: McDonnell Boehnen Hulbert & Berghoff LLP 
3:15 pm – 4:30 pm

The Federal Circuit's decision in Amgen Inc. v. Sanofi eliminated the “well-characterized antigen” test for compliance with the written description requirement for antibodies, thereby affecting how the courts and U.S. Patent and Trademark Office should apply the written description requirement to properly circumscribe the scope of claims to antibodies.  In addition, the U.S. Patent and Trademark Office's Interim Guidance on Patent Subject Matter Eligibility, and in particular, the Office's example on antibodies, delineated patent ineligible antibodies from those that are patent eligible.  This session will address compliance with the written description requirement and the subject matter eligibility of claims to antibodies, as well as differences in the patenting of antibodies in the United States and Europe.

Moderator: Donald Zuhn, Partner, McDonnell Boehnen Hulbert & Berghoff LLP


  • Kristan Lansbery, Director, Patent Attorney, Regeneron Pharmaceuticals, Inc.
  • Cara Coburn, Assistant General Counsel, Genentech
  • Charlotte Teall, Equity Partner, Forresters

Opening Keynote featuring Joseph Matal, former Interim Director of the United States Patent and Trademark Office and Senate Judiciary Committee Staff for the America Invents Act
Sponsored by: Seed Intellectual Property Law Group LLP
4:30 pm - 5:00 pm

Welcome Reception at Historic Napoleon House
Sponsored by: Brinks Gilson & Lione
5:30 pm -7:30 pm

Napoleon House
500 Chartres Street (.2 miles, 5 minute walk from Royal Sonesta)

Few places capture the essence of historic New Orleans like the Napoleon House: A 200 year old landmark and home of Nicholas Girod, mayor of New Orleans from 1812 to 1815. Girod offered his residence to Napoleon in 1821 as a refuge during his exile – and even though Napoleon never made it, the name stuck. Join your colleagues for cocktails and light bites in the ornate rooms and balconies that would have housed Bonaparte in this unique French Quarter destination.

Thursday, April 12, 2018

8:30 am – 9:30 am

Session 1 - Legal Developments, Cutting-Edge Cases and Practical Implications 
Sponsored by: WilmerHale
9:30 am – 10:45 pm

This panel will present on significant developments from the US Supreme Court, as well as notable lower court decisions, illustrating new developments and how recent trends in the law could impact the biotechnology industry. Topics will include, among others, venue jurisprudence post-TC Heartland and appeals from inter partes review, including standing to appeal and the intersection of patent and administrative law.

Speakers will discuss practical implications and tips from their varying perspectives as trial counsel, appellate counsel, and in-house counsel with emphasis on how to stay prepared in this ever-changing landscape.

Moderator: Lisa Pirozzolo, Partner and Co-Chair Intellectual Property Litigation Practice Group, WilmerHale


  • Thomas Saunders, Appellate and Supreme Court Litigation Partner, WilmerHale
  • Mark Rachlin, Senior Patent Counsel, GSK
  • Brenda Hefti, Vice President, Legal Services, Exelixis

Refreshment Break
10:45 am – 11:00 am

Session 2-  Patent Eligibility in a Post Mayo World
Sponsored by: Fenwick & West LLP
11:00 am – 12:15 pm

Since the U.S. Supreme Court decisions in Mayo and Myriad, innovators have had to navigate the now uncertain patent landscape surrounding diagnostic methods and personalized medicine. This panel will explore recent cases impacting the patent eligibility of inventions relating to diagnostics and personalized medicine, and discuss the implications for obtaining patent protection in this space. Panelists will also contemplate the current and long term effects on development of diagnostic medicine and the risk for innovation.

Moderator:  David Tellekson, Partner, Fenwick & West LLP


  • Ewa Davison, Ph.D., Associate, Fenwick & West LLP
  • Elias Lambiris, Director, Global IP Litigation, Novozymes
  • Matthew Gordon, Senior Director, Legal Affairs, Myriad Genetics       

Lunch Buffet
12:30 pm – 1:45 pm

Session 3- From Allegation to Adjudication: Preparing for Patent Litigation
Sponsored by: Rothwell Figg
2:00 pm – 3:15 pm

This panel will discuss how to prepare for litigation in Hatch-Waxman and Biosimilar cases. Speakers will offer practical tips on how to prepare your strongest case, prepare a budget, select litigation counsel, identify and retain experts, preserve documents, select a favorable venue, determine a litigation strategy, manage IPRs, position a case for settlement and for trial, and more. The panel is targeted at smaller companies that may have little or no experience litigating patent issues, but will offer insights and updates for seasoned litigators as well. Come with your questions for this lively panel of in-house and outside counsel who will share their experiences as both defendants and plaintiffs.

Moderator: Steve Lieberman, Shareholder, Rothwell, Figg, Ernst & Manbeck, P.C.


  • Dan Troy, Senior Vice President & General Counsel, GSK
  • Jennifer Nock, Associate, Rothwell, Figg, Ernst & Manbeck, P.C.
  • John Weidenbruch, General Counsel, Epizyme

Session 4- What’s on the Horizon? A Fireside Chat with Chief Judge Ruschke
Sponsored by: Foley Hoag LLP
3:30 pm – 4:45 pm

This session is an opportunity to hear from Chief Judge David Ruschke about the latest in U.S. Patent and Trial Appeal Board (PTAB) procedures and practices, recent trends, and potential changes to the PTAB in light of the confirmation of new Director Andrei Iancu. 

Moderator: Barbara Fiacco, Parter, Foley Hoag LLP


  • The Honorable David Ruschke, Chief Judge for the Patent Trial and Appeal Board, US Patent and Trademark Office

French Quarter Scavenger Hunt and Dinner Reception at Marché
5:30 pm – 8:30 pm *RSVP Only

Dinner Reception will begin at 7:00 pm
Sponsored by Fitzpatrick, Cella, Harper & Scinto

914 N. Peters St (.6 miles, 12 minute walk from Royal Sonesta)

Get to know a side of the French Quarter beyond Mardi Gras - with supernatural stories, historic landmarks, and beautiful outdoor enclaves during our (competitive!) 75-minute mobile scavenger hunt. Lead your team to bragging-rights-glory before dinner at the rooftop venue Marché, located in the French Market of New Orleans, with sweeping views of the Mississippi River. Located just 1.5 blocks from the original Café du Monde - don’t forget to pick up a beignet and coffee on your way home!
The group will meet outside of the IPCC session room no later than 5:30 pm to begin the scavenger hunt (Pro Tip: bring comfy shoes!). All hunts will conclude within walking distance to the reception dinner, where scavenger hunt winners and team superlatives will be announced!


Friday, April 13, 2018

8:30 am – 9:30 am

Session 5- Did You Forget Anything? Dealing with the Overlooked Provisions of the AIA
Sponsored by: Foley Hoag LLP
9:30 am – 10:45 am

Nearly seven years have passed since enactment of the America Invents Act (AIA). While provisions, such as post-issuance proceedings, are frequent topics of discussion, other infrequently-encountered areas have often baffled patent practitioners. In this panel, we will discuss the forgotten provisions of the AIA, including derivation proceedings, supplemental examination, prior art submissions, grace periods for inventor disclosures, and others

Moderator: Donald Ware, Partner, Foley Hoag LLP


  • Rebecca M. McNeill, Founding Partner, McNeill Baur PLLC
  • Jane E. Remillard, Partner, Nelson Mullins Riley & Scarborough LLP

Refreshment Break
10:45 am – 11:00 am

Session 6- If a Tree Falls in the Forest, Does it Make a Sound? Myths and Realities of “Evergreening” Patents
Sponsored by: Fenwick & West LLP
11:00 am – 12:15 pm

This panel will discuss secondary drug patents, also known as “evergreening” patenting. Panelists will explain the difference between primary and secondary patents, and address the myths and realities concerning secondary patents and their impact on market exclusivity of branded drugs.

Moderator: Melanie Mayer, Partner, Fenwick & West LLP


  • Paul Fehlner, Former Global Head of IP, Novartis
  • Chuck Sholtz, Vice President, Intellectual Property, Choerus BioSciences
  • Hans Sauer, Deputy General Counsel and Vice President, Intellectual Property, Biotechnology Innovation Organization (BIO)

Program Adjourns
12:15 pm

>>View the 2017 IPCC-Fall Program Agenda to learn more about our session topics and featured speakers!